MATERIALS AND METHODS

Chemicals and animals
The tested chemicals are listed in Table 1 with abbreviations. The uterotrophic assays were conducted at Hatano Research Institute, Food and Drug Safety Center. We selected the C57BL/6J mouse because it was reported to respond well to estrogens (Spearow et al., 1999; Ashby et al., 2003) and is also used widely as a background strain for production of genetically modified mice. Ovariectomized (OVX) mice (Japan SLC, Inc., Shizuoka, Japan) at 6 weeks of age were obtained from the Institute of Animal Reproduction (Ibaraki, Japan). Vaginal smears were checked for 4 days before the start of the test. At age 8 weeks, non-estrus mice were selected and housed six animals per cage, at room temperature of 23 ± 2°C, relative humidity between 40 and 75%, and a 12-hr light/ dark cycle. Feed (CE-2, CLEA Japan, Inc., Tokyo, Japan) and tap water were provided ad libitum. The estrogenicity of the feed was considered to be low enough for the performance of uterotrophic assay (Kato et al., 2004) . When the phytoestrogens were tested, phytoestrogen-low diet (PLD, Oriental Yeast Co., Tokyo, Japan) (Kanno et al., 2002; Kato et al., 2004) was provided. These animal studies were performed in accordance with the OECD Guidance Document on animal use (OECD, 2000) and the
Guidelines for Animal Experiments of Hatano Research
Institute, Food and Drug Safety Center.
Protocol
The protocol used in this study was described previously (Kanno et al., 2001) and in compliance with the OECD Test Guideline No.440 (OECD, 2007) . Briefly, OVX mice at age 8 weeks were randomly assigned to 11 groups (Table 2 ) of six mice each with similar average body weight. Treatment was by subcutaneous injection (sc) or oral gavage (po) at 24-hr intervals for 7 consecutive days (Fig. 1) . 17α-ethynyl estradiol (EE) was used as a reference control. Prior to testing, a dose-finding study was performed to find the maximal tolerated dose (MTD) which was employed as the highest dose.
For the detection of agonistic activity, vehicle, four different doses at a half-log ratio, and EE as a positive control, were tested (Table 2 , Groups 1 ~ 6). The amount of EE for the po study was 6 μg/kg po, and for the sc study was 0.2 μg/kg sc. These doses are known to significantly evoke 15 to 20% of the maximal uterotrophic response of EE (See Supplement Fig. 1 ).
For the detection of antagonistic activity, vehicle and the same four doses used for agonistic detection were administered with a reference dose of EE (Groups 7 ~ 11). For both sc and po studies 0.6 μg/kg EE was given by sc fifteen minutes after the administration of vehicle or the test compound. This amount of EE given by sc is known to evoke 60 to 70% of the maximal uterotrophic response by EE (See Supplement Fig. 1 ). The performance of the EE groups was used as a critical success factor of each study.
Vehicle, test substance preparation, and dosing
EE was dissolved in a minimal amount of ethanol (Wako Pure Chemical, Osaka, Japan) and then serially diluted with corn oil (Nacalai Tesque, Inc., Kyoto, Japan) to desired concentrations. Test substances were suspended or dissolved in the vehicle to prepare the dosing formulation of the desired concentrations (See Table 1 ). The top doses of each chemical are shown in Table 3 (See Supplement Table 2 for all doses). The amount administered was adjusted to the body weight (bw) on the day of treatment. The dosing volume was 2~4 ml/kg for sc and 5 ml/ kg for po. The animals were observed daily for clinical signs with the body weights recorded.
Necropsy and uterine weight measurement
Twenty-four hours after the last treatment, the animals were euthanized by cervical dislocation. The uterus was carefully dissected at the level of the vaginal fornix, trimmed of fascia and fat under a stereomicroscope and weighed including the luminal fluid (wet weight), and then pierced, gently blotted on moistened filter paper, and weighed (blotted weight).
Statistical analysis
Statistical analysis was performed on the less variable blotted uterine weight (UW) (Kanno et al., 2001) . For agonist detection, UW and body weight between the vehicle and each treated groups (Group 1 versus Groups 2~6) and for antagonist detection, between the EE group and each treated groups (Group 7 versus Groups 8~11)
were assessed for statistical significance by one-way analysis of variance (ANOVA). When significant, the Dunnett's Multiple Comparison Test was used to compare each treatment group with the control. p-value of less than 0.05 were considered significant.
Uterotrophic parameters
Because most of the studies lacked enough response range for reliable bench-mark dose fitting, the agonistic and antagonistic potential of each chemical were presented, alternatively, by two types of indicators, i.e. the lowest effect level (LOEL) and AGo 10 or AN 50 . The lowest dose that induced significant change in uterine weight was defined as LOEL. AGo 10 was defined as an interpolated dose that corresponded to 10% of the maximal agonistic uterotrophic effect. For this calculation, the uterotrophic response of positive control EE Group (Group 6) was considered as 20% of the maximal increase above the concurrent vehicle control (See Supplement Fig. 2 ). AN 50 was defined as an interpolated dose that suppresses the uterotrophic effect of the reference EE to 50% of the maximal uterotrophic response. For this calculation, the reference EE Group (Group 7) was considered as 70% of the maximal uterotrophic response above concurrent vehicle control (See Supplement Fig. 2) .
To compare agonistic and antagonistic potency of a chemical, ratio of LOELs, designated as AGo/AN, was used. A chemical with Ago/AN = 1 is considered equipotent in terms of agonistic/antagonistic potency. Likewise, the ratio of LOELs of po and sc, i.e. po/sc ratio is used to indicate the preferential exposure route.
RESULTS
A summary of the result is shown in Table 3 (See.  Supplement Table 2 for detail). All studies showed significant responses to EE treatments for detection of both agonistic and antagonistic effects.
Known estrogenic chemicals
BPA ( Fig. 2A, B ) by sc showed both agonistic and antagonistic effects at a similar dose response range, i.e. slight change at 30 mg/kg and significant effect at 100 and 300 mg/kg in a dose-dependent manner. The highest dose induced a 2-fold increase in uterine weight, which was two-third of that induced by 0.2 μg/kg EE sc. The same amount of BPA interfered with activity of 0.6 μg/kg EE sc by 70% reduction, i.e. from 10-fold increase down to 3-fold increase. Phytoestrogens; Genistein, Genistin, and Daidzein Genistein (Fig. 2C, D) by po showed significant agonistic effects at 200 and 600 mg/kg in a dose-dependent manner up to the uterotrophic level of 0.2 μg/kg EE sc. Significant antagonistic effect was monitored from 60 mg/kg in a dose-dependent manner. 600 mg/kg of Genistein reduced a 9-fold increase by 0.6 μg/kg EE sc down to a 3-fold increase in uterine weight.
Genistin (Fig. 2E, F) , a glucose-conjugated genistein, was given at higher doses equivalent to molar doses of genistein. Both agonistic and antagonistic responses were nearly identical to genistein, indicating that conjugated glucose was efficiently hydrolyzed under this condition.
Daidzein significantly but showed a slight agonistic activity at 600 mg/kg inducing a 1.5 fold increase in uterine weight. There was no significant antagonist effect.
chemical results
Chemicals positive for both agonistic and antagonistic effects (BHPMBA, THBP, DHBP, Tiratricol, NF and ANB)
Among the chemicals positive for both agonistic and antagonistic effects, BHPMBA (po and sc) and THBP (sc) are characterized by showing U-shaped dose-response curves in antagonistic studies (Fig. 3) . Both chemicals are half-log to 1 order more potent by the sc route than by the po route in both agonistic and antagonistic activities. It was noted that U-shaped dose-response curves were seen when agonistic uterotrophic responses were higher than that of the 0.6 μg/kg EE sc, which is the reference agonist for antagonistic study (Fig. 3B, D, H) . In other words, a dose which shows agonistic uterotrophic responses weaker than 0.6 μg/kg EE sc is antagonistic to the 0.6 μg/kg EE sc effect and a dose which shows an agonistic uterotrophic response higher than 0.6 μg/kg EE sc by itself exceeded the uterotrophic effect of the 0.6 μg/kg EE sc, thus generating a U-shaped dose response curve.
DHBP showed virtually no effect by the po route of exposure. By the sc route, clear agonistic and antagonistic effects were monitored in a dose-dependent manner with statistical significance at higher doses.
Tiratricol and NF showed weak but significant agonistic and antagonistic effect by both routes of exposure. The dose of 300 mg/kg of NF turned out to be lethally toxic by the sc route.
ANB showed weak agonistic effects at highest dose only by the sc route of exposure. Weak antagonistic effect was detected by both routes.
Chemicals showing weak agonistic effects only (PDD, DDB, BHB and Res).
PDD, DDB, BHB and Res showed weak agonistic effects at highest dose and only by the sc route of exposure. No agonistic effect was detected by the po route. All four lacked antagonistic effect by either route of exposure.
Chemicals showing antagonistic effects only (B[a]P, BTPP, RMA, B[a]A, MT, 6-gin, Col, DB[a,h]A, MGB, FBZ and LA)
B[a]P and BTPP were the typical cases that showed the antagonistic effect alone by both routes of exposure (Fig. 4) . B[a]P by po route showed a clear and dosedependent antagonistic effect from the lowest dose, and a weaker tendency by the sc route. BTPP showed a dosedependent antagonistic effect that was statistical significance from the lowest dose by both routes of exposure.
RMA, B[a]A, MT, 6-gin, Col and DB[a,h]
A showed antagonistic activity only by the sc route of exposure.
MGB, FBZ and LA were slight but significantly antagonistic by the po route of exposure.
Accordingly, three aryl hydrocarbons, i.e.
B[a]P, B[a] A and DB[A,h]
A were all antagonistic without agonistic effects.
Negative chemicals for both agonistic and antagonistic effects
HHB, TZV, Pra, PHS, NDGA, CP, DNB, PO, TBBPA, HMB, EP, PHB, K, BTC and PP were negative for agonistic and antagonistic responses by both route of exposure.
DISCUSSION
The mouse assay has successfully detected the agonistic effect of BPA with a comparable sensitivity to rat, i.e. significant agonistic effect at 100 mg/kg and above (Kanno et al., 2003b) . In addition, the antagonistic property of BPA was demonstrated. ERα transactivational potency of BPA is reported to be 5,000-to 10,000-fold less than that of EE (Yamasaki et al., 2002 ) (Supplement Table 1 ). Since the uterus is known to express predominantly ERα (Couse and Korach, 2004) , the simplest explanation would be the competitive binding of BPA against EE to the ERα ligand binding domain.
Molar equivalent dose of genistin (MW 432.4), a glucose-conjugated form of genistein (MW 270.2), was equipotent to that of genistein in both agonistic and antagonistic activity. This finding confirms that the glucoside is fully hydrolyzed to aglycone in this bioassay (Rowland et al., 2003; Walle et al., 2005; Wilkinson et al., 2003) .
The AGo/AN ratios of genistein and genistin were 200/60 > 1 and 300/100 > 1, respectively, suggesting that these phytoestrogens are more antagonistic to ERα than BPA which showed a ratio of 100/100 = 1.
Of the 36 chemicals tested, five chemicals showed agonistic effect with or without antagonistic effect by both route of exposure (Table 3, chemical No. 1~5) . Among them, NF, a dye, was newly shown as agonistic and antagonistic. BHPMBA (phenolphthalol) (Bitman and Cecil, 1970) and THBP (Yamasaki et al., 2003a) have been reported as estrogenic in the immature rat uterotrophic assay. We found that both chemicals have antagonistic activity, as potent as agonistic effects, i.e. AGo/AN = 1. For both chemicals, the po/sc ratio was smaller than 1, indicating sc is the more sensitive route. It was noted that these two chemicals showed U-shaped dose response curves in antagonistic studies (Fig. 3B, 3D, and 3H) . Apparently, the U-shaped doseresponse was seen when the maximal agonistic UT effect of a chemical was larger than the UT effect of the reference EE of the antagonistic study (Group 8). Other ago- nistic chemicals, including BPA and genistein, did not induce U-shaped dose-response because the UT effects at maximal dose (limited by MTD) were smaller than the reference EE (Group 8). We conducted a preliminary study on BPA to determine whether a U-shaped dose response curve can be seen by reducing the amount of reference EE to a level lower than the UT effect of the maximal dose. This attempt, however, failed to induce U-shaped dose response. Instead, an additive agonistic response was obtained; the uterine weight started to increase monotonously from the UT level of reduced reference EE (data not shown). There may be an absolute condition for a chemical to induce U-shaped dose response in an antagonistic study. ANB showed weak agonistic activiy by sc and weak antagonistic activity by both routes of exposure (chemical No.6 ). In sc study, antagonistic tendency emerged below the dose of agonistic effect.
Next four chemicals of the Table 1 ). However, a related compound, diphenylp-phenylenediamine, has been reported to be estrogenic (Yamasaki et al., 2003a) .
The next 11 chemicals in Table 3 (Chemicals No.11~21) only showed antagonistic effects. Among them, polycyclic aromatic hydrocarbons (PAHs), B[a]P, DB[a]A and B[a]A, are known, aside from their mutagenic and carcinogenic activities, to provoke aryl hydrocarbon receptor (AhR) signaling. In general, AhR agonists are reported to act as antiestrogens, not by competing at the ligand binding domain of the ERα, but by down-regulating ERα signaling (Chen et al., 2001) and/or increasing the metabolism of estradiol (Badawi et al., 2000) . AhR agonists are also reported to inhibit various growth factors and modulate crosstalk between AhR and ERα pathways (Safe, 1999) , and to increase proteosomal degradation of the ER receptor (Wormke et al., 2003) (Ohtake et al., 2011) . On the other hand, there are conflicting reports indicating that the hydroxylated metabolites of B[a]P are estrogenic in vitro (Fertuck et al., 2001 ) and both B[a]P and B [a] A are estrogenic in the immature rat uterotrophic assay after three days of sc (Kummer et al., 2008) . The discrepancy might be related to the difference between the immature and adult OVX assay, known to have different hepatic metabolism and/or to the length of the exposure periods (3 days versus 7 days). Further studies in AhR knock out and/or Cyp1a1 knockout mice might clarify the molecular basis of (anti)estrogenic effects of PAH. By the in vitro reporter assay (Supplement Table 1 ), B[a] P and MGB were antiestrogenic, and FBZ was estrogenic.
Col was selected as a candidate for the uterotrophic assay by QSAR and by ER alpha reporter assay. Therefore, Col might have interacted with ER alpha. However, its well known anti-mitogenic effect (given above human pharmacological doses) against the UT response might not be excluded. The remaining of the 11 chemicals were predicted to interact with ERα by in silico screening.
The last 15 chemicals in Table 3 (Chemical No. 22 ~ 36) were negative for estrogenic and antiestrogenic effects by both routes of exposure.
As a conclusion, we consider that the OVX mouse UT assay is an effective screening test method for the detection of estrogenic agonistic and antagonistic properties of a chemical, and may be comparable to the rat system. The advantage of mouse over rats are two fold: the smaller amount of test chemicals and laboratory space needed and the possibility to use transgenic and/or knockout mice, such as AhR/Cyp1a1 knock out and humanized mice, such as for cytochrome P450 (Scheer et al., 2008) and for steroid and xenobiotic receptor (Igarashi et al., 2012) for further mechanistic studies including that of U-shaped dose response.
